Skyward Specialty Insurance Group, Inc. (SKWD)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Skyward Specialty Insurance Group, Inc..
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 10 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Basics
Performance
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Analysts & Price Target
The price target sits 1.1% above the current price.
- Consensus
- Strong Buy
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Next Reporting Date
- Expected Earnings per Share
- 1.15 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 0.35 | -53.20 | 305 | 23.60 | 4.70 | 22 | 21 |
| 2025: Q1 | 1.02 | 13.50 | 331 | 25.30 | 12.70 | 97 | 97 |
| 2025: Q2 | 0.93 | 23.30 | 321 | 15.70 | 12.10 | 88 | 85 |
| 2025: Q3 | 1.10 | 23.90 | 382 | 26.50 | 12.00 | 171 | 169 |
| 2025: Q4 | 1.03 | 198.30 | 386 | 26.70 | 11.20 | 52 | 52 |
| 2026: Q1 | 1.19 | 16.80 | 396 | 19.70 | 12.60 | 117 | 118 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
About the Company
Skyward Specialty Insurance Group, Inc., eine Versicherungsholding, bietet gewerbliche Sach- und Schadenversicherungsdeckungen in den USA an.
| Employees | 611 |
|---|---|
| Headquarters | Houston, TX |
| Website | skywardinsurance.com |
| IPO Date | 13. Jan 2023 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Andrew Scott Robinson | Chairman of the Board & CEO | 1966 |
| Mark William Haushill CPA | Chief Financial Officer | 1962 |
| Patricia Anne Ryan | Chief Legal Officer and Corporate Secretary | 1970 |
| Sandip A. Kapadia FCAS, MAAA | President of Reinsurance & Head of Actuarial | 1981 |
| John Ambrose Burkhart | Executive VP & President of U.S. Property & Casualty | 1970 |
| Daniel Paul K. Bodnar | Chief Information & Technology Officer | 1967 |
| Kevin Reed | Vice President of Investor Relations | – |
| Haley Doughty | VP of Communications & Chief Marketing Officer | – |
| S. Shakoor Khan | Chief Strategy & Corporate Development Officer | 1979 |
| Kirby Allen Hill | Executive VP and Chairman of Captives & Specialty Programs | 1965 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.